| Code | 24987 | ||||||||||
| MA number | 58/0152/99-S | ||||||||||
| Product Form: | tbl 100x8 mg (fľ.HDPE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | CHEPLAPHARM Arzneimittel GmbH, Germany | ||||||||||
| Therapeutic Class: | 58 - HYPOTENSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 20.10.1999 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Atacand_09/2023.pdf
|
| PIL: |
PIL_Atacand 8mg_16mg_32mg_tbl_11_2023.pdf
|
| Safety feature | Yes |
| Data update: | 08.01.2018 |
